Smart Pills Market Size, Share, Analysis & Forecast 2022-27 The IMARC Group provides extensive analysis of the smart pills industry covering the market trends, investment opportunities, growth trends, statistics, and industry prospects. The report offers a comprehensive analysis of the industry, which comprises insights on smart pills market size, share, trends, analysis, growth, demand, statistics, and overview. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The market is segmented by size and region. The report provides an analysis of the key trends in each sub-segment of the market, along with forecasts at the global and regional level from 2022-2027. The report also includes competitive landscape of major key players in the industry along with emerging trends in the market.
Informed covered in the report:
- Historical market data from 2016-2021
- CAGR of the market during the forecast period 2022-2027
- Detailed information on factors that will drive market growth during the next five years
- Precise estimation of the Keyword market size and its contribution to the parent market
- Upcoming market trends and changes in consumer behavior
- A thorough analysis of the market’s competitive landscape and detailed information on key players
- Comprehensive details of factors that will challenge the growth of smart meters market key players
Request for a PDF sample of this report: https://www.imarcgroup.com/smart-pills-market/requestsample
The global smart pills market reached a value of US$ 3.9 Billion in 2021. Smart pills refer to the ingestible medical devices that comprise of sensors, cameras, trackers, patches, etc. They are utilized to record various physiological metrics and processes in the body. Smart pills aid in providing improved and accurate therapy, diagnostics, monitoring, etc., while eliminating the need for invasive procedures. At present, several manufacturers are introducing innovative product variants with advanced batteries and onboard memory. Smart pills also assist in remote patient monitoring and telemedicine. Additionally, they offer wireless transmission of information in real-time and precise measurement of the effects of the medication.
Smart Pills Market Trends:
The escalating prevalence of cancer and malignant gastrointestinal (GI) disorders is shifting the consumer preferences from conventional diagnostic techniques, such as endoscopy, which is primarily driving the smart pills market. In line with this, the increasing adoption of smart pills for providing multidimensional pictures of the body's internal parts non-invasively, over endoscopy devices which come with high risks of infection transmission and esophageal tearing, is further catalyzing the market growth. Moreover, the expanding pediatric population, who are relatively more vulnerable to targeted diseases, is acting as another significant growth-inducing factor. Besides this, the rising demand for minimally invasive surgeries (MIS) to diagnose and treat chronic diseases is also augmenting the global market. Furthermore, the elevating utilization of smart pills in the defense sector to monitor the core body temperatures of soldiers in real-time is positively influencing the product demand. This, in turn, is anticipated to fuel the smart pills market over the forecasted period. Looking forward, IMARC Group expects the global smart pills market to reach US$ 6.3 Billion by 2027, exhibiting at a CAGR of 7.8% during 2022-2027.
Checkout Now: https://www.imarcgroup.com/checkout?id=4568&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- CapsoVision Inc.
- Check-Cap Ltd.
- General Electric Company
- IntroMedic Co. Ltd.
- Jinshan Science & Technology (Group) Co. Ltd.
- Koninklijke Philips N.V.
- Medtronic plc
- Olympus Corporation
- PENTAX Medical (Hoya Corporation).
Breakup by Target Area:
- Esophagus
- Small Intestine
- Large Intestine
- Stomach
Breakup by Disease Indication:
- Esophageal Diseases
- Small Bowel Diseases
- Colon Diseases
- Others
Breakup by Application:
- Capsule Endoscopy
- Drug Delivery
- Patient Monitoring
Breakup by End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/smart-pills-market
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Trauma Care Centers Market: https://www.imarcgroup.com/trauma-care-centers-market
Laboratory Proficiency Testing Market: https://www.imarcgroup.com/laboratory-proficiency-testing-market
Extracorporeal Membrane Oxygenation Machine Market: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market
Medical Tapes and Bandages Market: https://www.imarcgroup.com/medical-tapes-bandages-market
Oligonucleotide Synthesis Market: https://www.imarcgroup.com/oligonucleotide-synthesis-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800